NEWS

Posts

Important Findings From Our Recently Published KRAS-Variant Study

A new study by MiraKind’s Founder, Dr. Joanne Weidhaas, in collaboration with her team at the University of California, Los Angeles and City of Hope, has been published in the scientific journal... Read More

New Research: “The KRAS-variant induces an epithelial-to-mesenchymal transition ‘EMT’ in normal breast epithelial cells”

As discussed in our previous Genetics series posts, the discovery of non-coding RNAs paved the way for changes in the Central Dogma and how we think about the flow of genetic information... Read More

New Research: How Inherited DNA -Based Mutations Impact Immunotherapy

The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we’ve spoken a lot... Read More

International Women’s Day Profile: Dr. Joanne Weidhaas

Here at MiraKind, we’re constantly inspired by the amazing women who surround us; whether it is scientists and doctors working on our research, or the strong and empowered women who are facing... Read More

Part 2 Q&A: Meet the MiraDx Research Team

“We’re pivoting from being focused on the disease to being focused on the patient and providing the tools to personalize each individual’s treatment.” –Mattias

Read More

Top 5 Reasons to Give a Charitable Donation this Holiday Season

This time of year, the malls and online stores are filled with shoppers, eager to purchase the perfect gift for friends and loved ones near and far. We may be biased, but... Read More

DONATE

SUPPORT OUR RESEARCH

PARTICIPATE

HELP ADVANCE OUR RESEARCH